Outsourcing STREAM

  1. We Are Altasciences: Proactive Drug Development 1/30/2023

    When you partner with Altasciences, you get a single source outsourcing partner who knows your program from end to end and who can anticipate your needs, for a seamless and simplified experience.

  2. Big Impact With A Personal Touch 1/30/2023

    Transforming lives. Improving human health. Bringing new therapies to life. Altasciences' CRO and CDMO services deliver.

  3. Altasciences Has You Covered From Coast To Coast 1/30/2023

    With your success in mind, we designed an integrated early phase drug development offering with eight locations, to get you from lead candidate selection to clinical proof of concept, and beyond.

  4. Trends In Sponsor-Of-Choice Initiatives: Consolidating Site Payments 5/5/2023

    Listen in as leaders from Bristol Myers Squibb, CenExel Centers of Excellence, and IQVIA Technologies discuss the importance of providing a consistent clinical trial payment experience to sites.

  5. See How You Can Start Your Early Phase Program 6-9 Weeks Earlier In Canada 3/23/2023

    Vice President of Business Development Lisa Sanford explains whether you need an IND before starting your first-in-human trial in Canada.

  6. How To Boost Disclosure Efficiencies With Outsourcing 11/1/2018

    In this webinar, you’ll hear about exciting new advisory and managed disclosure services from TrialScope, including: compliance, policy and process assessments, as well as plain-language summaries, protocol registration, results posting, and redaction services.

  7. How Sponsors Turn Disclosure As A Service Into A Strategic Advantage 5/18/2020

    In this panel discussion, Teva and Lung Biotechnology disclosure experts discuss why they opted for disclosure as a service. They will detail how it helps them safeguard regulatory compliance and mitigate risk.

  8. An Innovative Approach To Functional Outsourcing 8/27/2025

    The shifting dynamics of clinical research from the current funding dynamic to the increased complexity of drug development, requires a different approach to functional outsourcing to be successful.

  9. The Heart Of The Matter: Early Vs. Late QT Prolongation Testing 2/8/2023

    Dr. Beatrice Setnik, Altasciences' Chief Scientific Officer, walks through the differences between early and late QT prolongation testing.

  10. The Path Forward, Altasciences' Approach To Project Management 3/19/2024

    Learn about a unique, integrated program management strategy that can lower your costs and reduce program timelines from lead candidate selection to clinical proof-of-concept by up to 40%.